Oxygenta Pharmaceutical Ltd — Important, 19-08-2025: Company Update

Oxygenta Pharmaceutical has received requests from four current promoters to reclassify their status to 'public' shareholders. These individuals collectively hold 942,700 equity shares, representing 2.55% of the company. They state they are not involved in operations, management, or controlling company decisions, and have no special rights. The company will now undertake steps for this reclassification. This move, if approved, would increase the public shareholding, potentially enhancing stock liquidity and market perception for investors.